Mucormycosis-Black Fungus Infection in COVID | Daily Current Affairs 2021
1xbet 1xbet bahisno1 bahsegel casino siteleri ecopayz güvenilir bahis siteleri canlı bahis siteleri iddaa marsbahis marsbahis marsbahis marsbahis marsbahis marsbahis marsbahis marsbahis marsbahis marsbahis marsbahis marsbahis restbet canlı skor süperbahis mobilbahis marsbahis marsbahis marsbahis marsbahis
bahissenin tipobet betmatik

Mucormycosis-Black Fungus Infection in COVID

Posted by
Subscribe for News Feed

Mucormycosis, also known as black fungus infection is increasing among the COVID patients.

  • The National COVID Task Force recently issued an advisory against Mucormycosis.
  • This disease is rare but recently this disease has been increasing among COVID patients in Delhi, Gujarat and Maharashtra.

What is Mucormycosis?

  • Mucormycosis sometimes also called zygomycosis is a disease that mainly affects the skin, lungs and brain.
  • It is rare fungal infection.
  • It is caused by a group of molds called Mucoromycetes which are found in soil, leaves, or rotting woods.
  • The fungus can enter the body through breathing, open wounds or cuts.
  • It mainly affects people who are on medication.
  • The lungs or sinuses of the recovering COVID patients get affected after they inhale fungal spores from the air.
  • However, it is not a major threat to those with a healthy immune system.


  • It causes redness around the eyes, nose.
  • Also, the person suffers from headache, fever, bloody vomits, shortness of breath, altered mental status.
  • Mucormycosis is suspected when a person suffers from sinusitis, local pain on cheek bone, blackish discoloration over bridge of nose, chest pain, thrombosis, plural effusion, necrosis, blurred vision, etc.

How can it be diagnosed?

  • You should see a doctor if you are experiencing the above symptoms post the COVID recovery.
  • A definite diagnosis will be made by the identification of fungi in the patient’s tissue.
  • For this, a doctor may collect a sample of your nasal discharge.


  • Mucormycosis might lead to loss of eyes or upper jaws.
  • Such patients might require a surgery.
  • The treatment of Mucormycosis includes infusion of saline, Amphotericin and other anti-fungal therapies.

Task Force Advisory:

  • Advisory goes on to say that Mucormycosis, if uncared for, may turn fatal.
  • To prevent disease, blood glucose level should be monitored post-Covid discharge
  • The COVID Task Force has recommended to control hyperglycemia after discharge.

Why are COVID patients susceptible to Mucormycosis?

  • The immunity level of a person recovering from COVID-19 is very low.
  • The Mucoromycetes easily affects persons with very low immunity levels.
  • It is especially common among COVID patients who are treated with steroids to reduce inflammation.
  • Inflammation is a condition where a part of the body is swollen, reddened and is often painful due to an infection or reaction to injury.

Subscribe for News Feed